Tirzepatide (Leu-13C6,15N) TFA
Description
Tirzepatide (Leu-13C6,15N) (LY3298176 (Leu-13C6,15N)) TFA is the 13C- and 15N-labeled Tirzepatide TFA (HY-P1731A). Tirzepatide TFA (LY3298176 hydrochloride) is a glucose-dependent insulin nutritive polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist. Tirzepatide TFA has neuroprotective effects and can be used in the study of type 2 diabetes, diabetes-related neuropathy and obesity.
Product Information
| Product Name | Tirzepatide (Leu-13C6,15N) TFA |
| Molecular Weight | 4820.40 (free base) |
| Formula | C21913C6H348N4715NO68??xC2HF3O2 ?DZ?? CAS 2023788-19-2 |
| Sequence | Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-{Leu-13C6,15N}-Asp-Lys-Ile-Ala-Gln-{C20 diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Sequence Shortening | Y-{Aib}-EGTFTSDYSI-{Aib}-{Leu-13C6,15N}-DKIAQ-{C20 diacid-gamma-Glu-(AEEA)2-Lys}-AFVQWLIAGGPSSGAPPPS-NH2 |
